The Super Bowl Ads Go All in on Health and Longevity
IF YOU WATCHED the Super Bowl last night, you were in for a treat. The Seattle Seahawks dominated…
Lifetime heavy drinking sharply raises colorectal cancer risk, major US study finds
A large US trial shows that the cumulative burden of alcohol over decades matters for colorectal cancer risk,…
New trial tests strategies to protect heart health during prostate cancer therapy
City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States…
Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers
The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents…
New Zealand needs to do more to promote early prostate cancer detection – Geof Mortlock
The case for a prostate cancer screening programme is at least as justified as for bowel cancer, breast…
Sir Cliff Richard discovered he had cancer while preparing for NZ tour – NZ Herald
Sir Cliff Richard discovered he had cancer while preparing for NZ tour NZ HeraldUK pop star Sir Cliff Richard…
Early scans reveal prostate radiotherapy toxicity risk
Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk…
Prostate cancer: the silent disease that affects one in eight Malaga province residents
Thursday, 27 November 2025, 20:07 One in eight men will be diagnosed with prostate cancer in their lifetime,…
National initiative helps reduce missed radiation appointments for cancer patients
A national quality improvement program led by the American College of Surgeons (ACS) found that transportation barriers and…
Oasis guitarist Paul ‘Bonehead’ Arthurs reveals prostate cancer diagnosis
“I’m really sad to be missing these shows but I’m feeling good and will be back ready to…
Genetic risk scores fail to predict survival after diagnosis
New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead,…
New T cell therapy targets CTNNB1 cancer mutation with promising results in animal studies
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the…